tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
SMMT
Summit Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
SMMT Chart

Summit Therapeutics (SMMT) Stock News & Sentiment

Compare
1,403 Followers
Is SMMT a Buy, Before Earnings?
Premium
Pre-Earnings
Is SMMT a Buy, Before Earnings?
12h ago
SMMT
Summit Therapeutics Receives Buy Rating Amid Promising Ivonescimab Developments and Strategic Trials
Premium
Ratings
Summit Therapeutics Receives Buy Rating Amid Promising Ivonescimab Developments and Strategic Trials
4d ago
SMMT
Mitchell Kapoor Reaffirms Buy Rating for Summit Therapeutics Amid Promising Ivonescimab Trial Results
Premium
Ratings
Mitchell Kapoor Reaffirms Buy Rating for Summit Therapeutics Amid Promising Ivonescimab Trial Results
5d ago
SMMT
Positive Phase 3 Trial Results for Ivonescimab Boost Confidence in Summit Therapeutics’ NSCLC Prospects
Premium
Ratings
Positive Phase 3 Trial Results for Ivonescimab Boost Confidence in Summit Therapeutics’ NSCLC Prospects
6d ago
SMMT
Insider Moves: Paychex, Summit, eXp, Humacyte, Williams-Sonoma
Premium
Weekend Updates
Insider Moves: Paychex, Summit, eXp, Humacyte, Williams-Sonoma
17d ago
WSM
EXPI
Optimistic Buy Rating for Summit Therapeutics Driven by Promising HARMONi-2 Trial and Favorable Regulatory Pathway in China
Premium
Ratings
Optimistic Buy Rating for Summit Therapeutics Driven by Promising HARMONi-2 Trial and Favorable Regulatory Pathway in China
22d ago
SMMT
Promising Potential of Ivonescimab in Oncology: A Buy Recommendation for Summit Therapeutics
Premium
Ratings
Promising Potential of Ivonescimab in Oncology: A Buy Recommendation for Summit Therapeutics
29d ago
SMMT
More SMMT News >

SMMT News on the Web

Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?
Zacks
Neutral
Summit Therapeutics selloff Friday on data overdone, says H.C. Wainwright
The Fly
Neutral
Summit Therapeutics (SMMT) Shares Plummet After Survival Data Disappoints
GuruFocus News
Neutral
Why Summit Therapeutics Inc.amp;#8217;s (SMMT) Stock Is Up 6.58%
AAII
Neutral
Market Today: Alphabet's Earnings Boost Tech, Summit Therapeutics Plummets
GuruFocus News
Neutral
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today
The Motley Fool
Neutral
Summit Therapeutics (SMMT) Observes Notable Progress with Ivonescimab Approval | SMMT Stock News
GuruFocus News
Neutral
Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically ...
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
SMMT
Sector Average
Media Buzz
This Week17 articles
Weekly Average8.25 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SMMT’s Media Buzz Sentiment?
17 articles about SMMT were published this week. In an average week, 8.25 articles are published.
    What is SMMT’s weekly average amount of articles?
    In an average week, 8.25 articles about SMMT are published.
      What is SMMT’s News Sentiment?
      100% of articles about SMMT were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        SWTXSpringworks Therapeutics
        URGNUrogen Pharma
        JAGXJaguar Animal Health
        AZNAstraZeneca
        EWEdwards Lifesciences
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing